A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell. The work, ...

"This type of prevention can be very useful in controlling infection outbreaks and containing the bird flu pandemic," said an immunologist.

Genmab A/S (NASDAQ:GMAB), a Danish biotechnology company specializing in antibody therapeutics for cancer treatment, finds itself at a crucial juncture. With a strong portfolio of approved medicines ...

This study presents a valuable finding on the alterations in the autophagic-lysosomal pathway in a Huntington's disease model. The evidence supporting the claims of the authors is solid. However, the ...

Xencor Inc . (NASDAQ:XNCR), a biopharmaceutical company specializing in innovative therapies for immunology and oncology, ...

Atmos Space Cargo will fly its first Phoenix cargo-return capsule on SpaceX's Bandwagon 3 rideshare mission, which is ...

The CuRVE framework and its implementation in eFLASH mark a significant advancement in volumetric single-cell analysis.

Scientists have discovered a new type of anti-malarial antibody that doesn't interfere with current vaccines, at least in mouse models. Could they help eliminate malaria in the future?

Thyroid disease is often missed in older adults because its symptoms overlap with those of “normal aging.” In this ...

Scientists have discovered a new type of anti-malarial antibody that doesn't interfere with current vaccines, at least in mouse models. Could they help eliminate malaria in the future? https://p ...

Vijay Pande, PhD, founding investor of Andreessen Horowitz's Bio + Health fund and a general partner with the tech venture capital firm , discusses how AI’s uptake in healthcare will shape its ...

Analysts have recently evaluated AnaptysBio and provided 12-month price targets. The average target is $36.17, accompanied by ...